Page last updated: 2024-08-24

3-iodobenzylguanidine and 3-tyr-octreotide

3-iodobenzylguanidine has been researched along with 3-tyr-octreotide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Besser, GM; Bomanji, J; Britton, KE; Ellison, D; Grossman, A; Mather, S; Moyes, J1
Carnaille, B; Huglo, D; Marchandise, X; Nocaudie-Calzada, M; Proye, C1

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and 3-tyr-octreotide

ArticleYear
A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:6

    Topics: 3-Iodobenzylguanidine; Aged; Carcinoid Tumor; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Octreotide; Radionuclide Imaging

1992
Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:11

    Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Contrast Media; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Octreotide; Pentetic Acid; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity

1996